Does iron deficiency contribute to depressive symptoms, and can iron supplementation improve mood?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Iron Deficiency and Mood: Evidence-Based Recommendations

Iron deficiency, even without anemia, significantly contributes to depressive symptoms, fatigue, and impaired quality of life, and iron supplementation can improve these psychological symptoms, particularly when serum ferritin is below 100 ng/mL.

Understanding the Iron-Mood Connection

Iron plays essential roles beyond hemoglobin production—it's critical for neurotransmitter synthesis, energy metabolism in brain cells, and mitochondrial function 1. The evidence clearly demonstrates that iron deficiency affects mood and cognitive function before frank anemia develops.

Key Diagnostic Thresholds

Screen for iron deficiency when patients present with:

  • Fatigue, reduced concentration, or irritability
  • Depressive symptoms or anxiety
  • Sleep disturbances or restless legs
  • Hair loss or reduced exercise tolerance

Diagnostic criteria for iron deficiency:

  • Ferritin <30 ng/mL indicates absolute iron deficiency 2
  • Ferritin 30-100 ng/mL with transferrin saturation <20% suggests combined iron deficiency 2
  • In the presence of inflammation, ferritin up to 100 µg/L may still reflect iron deficiency 3

Evidence for Mood Improvement with Iron Supplementation

The most recent and highest quality evidence demonstrates substantial benefits:

A 2025 meta-analysis 4 of randomized controlled trials in non-anemic individuals showed iron supplementation improved:

  • Anxiety symptoms (effect size d = 0.34)
  • Fatigue (d = 0.34)
  • Physical well-being (d = 0.42)
  • Cognitive intelligence (d = 0.46)
  • Short-term memory (d = 0.53)

Pre-post studies showed even larger improvements in depression (d = 0.93), fatigue (d = 1.01), and overall psychiatric symptoms (d = 1.13) 4.

In children and adolescents 5, iron supplementation for hypoferritinemia (ferritin <30 ng/mL) over 12 weeks significantly improved:

  • Clinical Global Impression scores
  • Depression scores (CES-D)
  • Sleep quality (PSQI)
  • Mood states across multiple domains
  • School attendance rates

Notably, these improvements occurred even though no participant had hemoglobin <12 g/dL, confirming that iron deficiency without anemia causes significant psychological symptoms 5.

Treatment Algorithm

Step 1: Initial Iron Supplementation Strategy

For patients with ferritin <100 ng/mL and mood symptoms:

Oral iron (first-line for most patients):

  • Start with 35-65 mg elemental iron daily 6
  • Consider alternate-day dosing to improve absorption and tolerability 3
  • Maximum 100 mg elemental iron daily in patients with inflammatory conditions 3
  • Expect response within 4 weeks (hemoglobin rise ≥1.0 g/dL) 6

Intravenous iron (first-line in specific situations):

  • Active inflammatory bowel disease with moderate-severe anemia (Hb <10 g/dL) 2
  • Oral iron intolerance or malabsorption 2
  • Need for rapid correction of severe symptoms 2
  • Previous gastric surgery or celiac disease 7, 8

Step 2: Dosing Specifics

For IV iron:

  • Simple dosing: 500-1000 mg total dose for ferritin <100 ng/mL 2
  • Can use ferric carboxymaltose 500 mg weekly until ferritin >100 ng/mL, then monthly maintenance 2
  • Reassess at 4 weeks for hemoglobin and ferritin response 6

Step 3: Target Goals

Aim to achieve:

  • Hemoglobin normalization (≥12 g/dL women, ≥13 g/dL men) 2
  • Ferritin >100 ng/mL to prevent rapid recurrence 2
  • Transferrin saturation >20% 2

Step 4: Monitoring and Maintenance

Monitor every 3 months for the first year after correction, then every 6-12 months 2

Re-treat when:

  • Ferritin drops below 100 ng/mL, or
  • Hemoglobin falls below 12 g/dL (women) or 13 g/dL (men) 2

Critical Clinical Considerations

Quality of life improvements occur independent of disease activity 2. This means treating iron deficiency improves mood symptoms even when underlying inflammatory conditions persist.

The evidence for treating iron deficiency without anemia is strongest in:

  • Chronic fatigue syndromes 2
  • Heart failure 9, 10
  • Psychiatric symptoms (depression, anxiety, ADHD) 4
  • Children and adolescents with concentration difficulties 5

Common pitfalls to avoid:

  • Waiting for anemia to develop before treating—psychological symptoms occur with iron deficiency alone 4
  • Using oral iron in active inflammatory conditions—absorption is impaired 3
  • Undertreating—targeting ferritin >100 ng/mL prevents recurrence better than lower targets 2
  • Missing iron deficiency in menstruating women due to sex-specific hemoglobin thresholds 11

Special Populations

Adolescents with heavy menstrual bleeding: 51% with iron deficiency anemia had depression scores ≥10, and depression improved significantly when hemoglobin improved 12. Address both the bleeding source and iron repletion.

Postpartum women: Gestational iron supplementation prevents postpartum depressive symptoms and preserves neuronal density in frontal cortex 13.

Inflammatory bowel disease: Quality of life improves with iron correction independent of clinical disease activity 2. Use IV iron as first-line in active disease 2.

When to Investigate Further

If inadequate response to iron replacement occurs, evaluate for:

  • Ongoing blood loss exceeding iron intake 7
  • Malabsorption syndromes (celiac disease, H. pylori) 7, 8
  • Anemia of chronic disease 2
  • Other micronutrient deficiencies (B12, folate) 3
  • Bone marrow disorders 2

The evidence is clear: iron deficiency causes mood symptoms before anemia develops, and treating iron deficiency improves psychological well-being 4, 5. Don't wait for anemia—screen ferritin in patients with unexplained fatigue, depression, or cognitive symptoms, and treat when ferritin is <100 ng/mL.

References

Research

Iron Supplementation for Hypoferritinemia-Related Psychological Symptoms in Children and Adolescents.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2022

Guideline

management of anemia in patients with congestive heart failure.

American Journal of Hematology, 2017

Related Questions

In a 10-year-old patient with anxiety and insomnia, normal hemoglobin but low ferritin (21 ng/mL) despite a diet rich in meat and legumes, could iron deficiency be contributing to her anxiety and sleep difficulty, and should she receive iron supplementation?
In a 15-year-old female with three months of low mood, irritability, school refusal, insomnia with early morning awakening, decreased appetite, 6‑lb unintentional weight loss, fatigue, dizziness, PHQ‑9 (Patient Health Questionnaire‑9) score of 14 with passive suicidal thoughts, heavy menstrual bleeding lasting 7–8 days, pale conjunctiva, hemoglobin 10.2 g/dL and MCV (mean corpuscular volume) 74 fL, what are the most likely differential diagnoses and how can symptoms of iron‑deficiency anemia be distinguished from those of major depressive disorder (MDD) using current pediatric/adolescent guidelines?
Which non‑pharmacologic interventions, aside from psychotherapy, are appropriate for a 16‑year‑old adolescent with newly diagnosed major depressive disorder, low iron (possible anemia), low physical activity, fatigue, low mood, and self‑scratching behavior?
In a 15‑year‑old female with iron‑deficiency anemia (hemoglobin 10.2 g/dL, mean corpuscular volume 74 fL) and depression (PHQ‑9 14), how do these laboratory findings affect the prioritization and urgency of her treatment?
A 24-year-old female with headache and fatigue has ferritin 15 µg/L, serum iron 39 µg/dL, and transferrin saturation 11 % while on oral iron therapy; should she be switched to intravenous iron?
What is the difference between obstructive sleep apnea (OSA) and obstructive sleep apnea syndrome (OSAS)?
What is the appropriate anticoagulation and overall management for an amputee patient with acute deep vein thrombosis and concurrent pneumonia?
What is the likely diagnosis and appropriate management for a patient with increased bowel gas on plain radiography but no air‑fluid levels?
What is the appropriate treatment for a milk bleb in a newborn?
Can a patient be treated with both Brilinta (ticagrelor) and heparin (unfractionated heparin) simultaneously?
What is the appropriate management of symptomatic hyponatraemia and ascites?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.